Abstract
Colorectal and endometrial cancer are the characteristic tumors of the Lynch syndrome. We reviewed the available evidence on the occurrence of other types of cancer in the syndrome, aiming to identify those types that can be included in the tumor spectrum, based on this evidence. We chose to define the tumor spectrum as comprising the cancers for which Lynch syndrome patients are at elevated risk. We found sufficiently strong and consistent evidence to include gastric cancer, small bowel cancer, hepatobiliary tract cancer, upper urologic tract cancer, ovarian cancer, and brain tumors in this spectrum, in addition to colorectal and endometrial cancer. We predict that the spectrum will expand as additional studies are reported, especially as prospective studies of mutation carriers are completed.
Similar content being viewed by others
References
HT Lynch A. Chapelle Particlede la (2003) ArticleTitleGenomic medicine: Hereditary colorectal cancer N Engl J Med 348 919–32 Occurrence Handle10.1056/NEJMra012242 Occurrence Handle12621137
J Wijnen W Leeuw Particlede H Vasen et al. (1999) ArticleTitleFamilial endometrial cancer in female carriers of MSH6 germline mutations Nat Genet 23 142–4 Occurrence Handle10.1038/13773 Occurrence Handle10508506
M Aarnio R Sankila E Pukkala et al. (1999) ArticleTitleCancer risk in mutation carriers of DNA-mismatch-repair genes Int J Cancer 81 214–8 Occurrence Handle10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L Occurrence Handle10188721
HFA Vasen JT Wijnen FH Menko et al. (1996) ArticleTitleCancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis Gastroenterology 110 1020–7 Occurrence Handle8612988
MG Dunlop SM Farrington AD Carothers et al. (1997) ArticleTitleCancer risk associated with germline DNA mismatch repair gene mutations Hum Mol Genet 6 105–10 Occurrence Handle10.1093/hmg/6.1.105 Occurrence Handle9002677
MH Gail D Pee J Benichou et al. (1999) ArticleTitleDesigning studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs Genet Epidemiol 16 15–39 Occurrence Handle10.1002/(SICI)1098-2272(1999)16:1<15::AID-GEPI3>3.0.CO;2-8 Occurrence Handle9915565
AC Jäger ML Bisgaard T Myrhøj et al. (1997) ArticleTitleReduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression Am J Hum Genet 61 129–138 Occurrence Handle9245993
P Watson HT. Lynch (2001) ArticleTitleCancer risk in mismatch repair gene mutation carriers Familial Cancer 1 57–60 Occurrence Handle10.1023/A:1011590617833 Occurrence Handle14574017
Y Parc C Boisson G Thomas et al. (2003) ArticleTitleCancer risk in 348 French MSH2 or MLH1 gene carriers J Med Genet 40 208–13 Occurrence Handle10.1136/jmg.40.3.208 Occurrence Handle12624141
SJ Cai Y Xu GX Cai et al. (2003) ArticleTitleClinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer World J Gastroenterol 9 284–7 Occurrence Handle12532449
YJ Park K-H Shin J-G. Park (2000) ArticleTitleRisk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea Clin Cancer Res 6 2994–8 Occurrence Handle10955776
JI Risinger JC Barrett P Watson et al. (1996) ArticleTitleMolecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal cancer syndrome Cancer 77 1836–43 Occurrence Handle10.1002/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0 Occurrence Handle8646682
J Boyd E Rhei MG Federici et al. (1999) ArticleTitleMale breast cancer in the hereditary nonpolyposis colorectal cancer syndrome Breast Cancer Res Treat 53 87–91 Occurrence Handle10.1023/A:1006030116357 Occurrence Handle10206076
A Müller T Bocker Edmonston DA Corao et al. (2002) ArticleTitleExclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer Cancer Res 62 1014–9 Occurrence Handle11861375
FO Ferreira CC Napoli Ferreira BM Rossi et al. (2004) ArticleTitleFrequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: an analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry Fam Cancer 3 41–7 Occurrence Handle10.1023/B:FAME.0000026810.99776.e9 Occurrence Handle15131405
RJ Scott M McPhillips CJ Meldrum et al. (2001) ArticleTitleHereditary nonpolyposis colorectal cancer in 95 families: Differences and similarities between mutation-positive and mutation-negative kindreds Am J Hum Genet 68 118–27 Occurrence Handle10.1086/316942 Occurrence Handle11112663
HFA Vasen H Morreau JWR. Nortier (2001) ArticleTitleIs breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68 1533–4 Occurrence Handle10.1086/320610 Occurrence Handle11359214
MA den Bakker C Seynaeve M Kliffen et al. (2003) ArticleTitleMicrosatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary nonpolyposis colorectal cancer Histopathology 2003 IssueID43 297–9 Occurrence Handle10.1046/j.1365-2559.2003.01681.x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Watson, P., Riley, B. The Tumor Spectrum in the Lynch Syndrome. Familial Cancer 4, 245–248 (2005). https://doi.org/10.1007/s10689-004-7994-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10689-004-7994-z